Winston Kung, MBA, serves as the Chief Financial Officer and Treasurer at ARRIVENT BIOPHARMA INC, a position he has held with distinction. With an extensive background in finance and biotechnology, Winston brings a wealth of experience to his role. He earned his MBA from a prestigious institution, which laid the foundation for his successful career in financial management within the life sciences sector. Prior to joining ARRIVENT, Winston held significant positions at several leading biopharmaceutical companies, where he was instrumental in driving financial strategies that supported growth and innovation. At ARRIVENT BIOPHARMA INC, Winston Kung plays a pivotal role in steering the company's financial direction. His responsibilities include overseeing the company's financial planning, budgeting, and reporting processes, as well as managing investor relations. Under his leadership, ARRIVENT has achieved notable financial stability and growth, enabling the company to advance its mission of developing innovative cancer therapies. Winston's strategic vision and financial acumen have been crucial in securing funding for research and development initiatives, ensuring that ARRIVENT remains at the forefront of the biopharma industry. His contributions have not only bolstered the company's financial health but have also supported its broader goals of improving patient outcomes through cutting-edge treatments.